A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A population-based study of tuberculosis incidence among rheumatic disease patients under anti-TNF treatment
Authors
Keywords
-
Journal
PLoS One
Volume 14, Issue 12, Pages e0224963
Publisher
Public Library of Science (PLoS)
Online
2019-12-03
DOI
10.1371/journal.pone.0224963
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Soluble immune effector molecules [I]: anti-tumor necrosis factor-α agents)
- (2018) J.W. Baddley et al. CLINICAL MICROBIOLOGY AND INFECTION
- Risk of tuberculosis in patients with immune-mediated diseases on biological therapies: a population-based study in a tuberculosis endemic region
- (2018) Xing Wang et al. RHEUMATOLOGY
- Comparison of the risk of infections in different anti-TNF agents: a meta-analysis
- (2017) Hongxing Liao et al. International Journal of Rheumatic Diseases
- Incidência de tuberculose em pacientes com artrite reumatoide em uso de bloqueadores do TNF no Brasil: dados do Registro Brasileiro de Monitoração de Terapias Biológicas BiobadaBrasil
- (2017) Claudia Leiko Yonekura et al. Revista Brasileira De Reumatologia
- Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis
- (2016) Gerd R Burmester et al. ANNALS OF THE RHEUMATIC DISEASES
- Characteristics Predicting Tuberculosis Risk under Tumor Necrosis Factor- Inhibitors: Report from a Large Multicenter Cohort with High Background Prevalence
- (2016) B. Kisacik et al. JOURNAL OF RHEUMATOLOGY
- A real-world risk analysis of biological treatment (adalimumab and etanercept) in a country with a high prevalence of tuberculosis and chronic liver disease: a nationwide population-based study
- (2016) Y-M Chiu et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Guidance for the management of patients with latent tuberculosis infection requiring biologic therapy in rheumatology and dermatology clinical practice
- (2015) Fabrizio Cantini et al. AUTOIMMUNITY REVIEWS
- Risk of infection with biologic antirheumatic therapies in patients with rheumatoid arthritis
- (2015) Manjari Lahiri et al. BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
- Biologic therapy for inflammatory arthritis and latent tuberculosis: real world experience from a high prevalence area in the United Kingdom
- (2015) Muhammad K. Nisar et al. CLINICAL RHEUMATOLOGY
- The Risk of Tuberculosis in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor- Antagonist: A Metaanalysis of Both Randomized Controlled Trials and Registry/Cohort Studies
- (2015) J.-W. Ai et al. JOURNAL OF RHEUMATOLOGY
- ERRATA
- (2014) INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patients
- (2014) Takao Koike et al. Modern Rheumatology
- Risk of tuberculosis in rheumatoid arthritis patients on tumour necrosis factor-alpha inhibitor treatment in Taiwan
- (2013) W-M. Ke et al. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE
- Mycobacterial Infections in Patients Treated with Tumor Necrosis Factor Antagonists in South Korea
- (2013) Sang Kook Lee et al. LUNG
- Infections in patients treated with tumor necrosis factor antagonists: incidence, etiology and mortality in the BIOBADASER registry
- (2011) María José Pérez-Sola et al. MEDICINA CLINICA
- Tuberculosis infection in rheumatic patients with infliximab therapy: experience with 157 patients
- (2011) Christiane Aguiar Nobre et al. RHEUMATOLOGY INTERNATIONAL
- Registries in rheumatoid arthritis and autoimmune diseases: data from the French registries
- (2010) X. Mariette et al. RHEUMATOLOGY
- Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR)
- (2009) W. G. Dixon et al. ANNALS OF THE RHEUMATIC DISEASES
- III Diretrizes para Tuberculose da Sociedade Brasileira de Pneumologia e Tisiologia
- (2009) Marcus Barreto Conde et al. Jornal Brasileiro de Pneumologia
- Serious infections during anti-TNFα treatment in rheumatoid arthritis patients
- (2008) Ennio Giulio Favalli et al. AUTOIMMUNITY REVIEWS
- Risk factors for opportunistic infections in infliximab-treated patients: the importance of screening in prevention
- (2008) C. Garcia-Vidal et al. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
- Tumour necrosis factor antagonists: structure, function, and tuberculosis risks
- (2008) Robert S Wallis LANCET INFECTIOUS DISEASES
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now